Cochlear Inkomsten in het verleden

Verleden criteriumcontroles 3/6

Cochlear is de winst gegroeid met een gemiddeld jaarlijks percentage van 22.8%, terwijl de Medical Equipment industrie de winst jaarlijks groeide met 8.3%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 10.6% per jaar. Het rendement op eigen vermogen van Cochlear is 19.4%, en het heeft een nettomarge van 16%.

Belangrijke informatie

22.8%

Groei van de winst

20.5%

Groei van de winst per aandeel

Medical Equipment Groei van de industrie5.8%
Inkomstengroei10.6%
Rendement op eigen vermogen19.4%
Nettomarge16.0%
Volgende winstupdate13 Feb 2025

Recente prestatie-updates uit het verleden

Recent updates

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Nov 19
Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

Nov 04
Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

We Think Shareholders May Consider Being More Generous With Cochlear Limited's (ASX:COH) CEO Compensation Package

Oct 18
We Think Shareholders May Consider Being More Generous With Cochlear Limited's (ASX:COH) CEO Compensation Package

Cochlear Limited's (ASX:COH) Shareholders Might Be Looking For Exit

Sep 19
Cochlear Limited's (ASX:COH) Shareholders Might Be Looking For Exit

Cochlear Limited Just Missed EPS By 7.4%: Here's What Analysts Think Will Happen Next

Aug 16
Cochlear Limited Just Missed EPS By 7.4%: Here's What Analysts Think Will Happen Next

Investors Could Be Concerned With Cochlear's (ASX:COH) Returns On Capital

Aug 01
Investors Could Be Concerned With Cochlear's (ASX:COH) Returns On Capital

Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching

Jun 08
Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching

Cochlear (ASX:COH) Might Be Having Difficulty Using Its Capital Effectively

Mar 27
Cochlear (ASX:COH) Might Be Having Difficulty Using Its Capital Effectively

Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching

Feb 21
Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching

Cochlear (ASX:COH) Might Be Having Difficulty Using Its Capital Effectively

Dec 18
Cochlear (ASX:COH) Might Be Having Difficulty Using Its Capital Effectively

Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

Oct 04
Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

Cochlear (ASX:COH) Could Be Struggling To Allocate Capital

Sep 12
Cochlear (ASX:COH) Could Be Struggling To Allocate Capital

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Jun 05
Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly

Apr 05
Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Mar 04
Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Is Cochlear (ASX:COH) A Risky Investment?

Dec 19
Is Cochlear (ASX:COH) A Risky Investment?

Is Cochlear Limited (ASX:COH) Worth AU$205 Based On Its Intrinsic Value?

Nov 16
Is Cochlear Limited (ASX:COH) Worth AU$205 Based On Its Intrinsic Value?

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Oct 25
The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Should Shareholders Reconsider Cochlear Limited's (ASX:COH) CEO Compensation Package?

Oct 11
Should Shareholders Reconsider Cochlear Limited's (ASX:COH) CEO Compensation Package?

Cochlear's (ASX:COH) Upcoming Dividend Will Be Larger Than Last Year's

Aug 28
Cochlear's (ASX:COH) Upcoming Dividend Will Be Larger Than Last Year's

Here's Why Cochlear (ASX:COH) Can Manage Its Debt Responsibly

Aug 23
Here's Why Cochlear (ASX:COH) Can Manage Its Debt Responsibly

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Jul 16
The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

A Look At The Fair Value Of Cochlear Limited (ASX:COH)

May 19
A Look At The Fair Value Of Cochlear Limited (ASX:COH)

Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal

Apr 09
Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal

Estimating The Intrinsic Value Of Cochlear Limited (ASX:COH)

Feb 04
Estimating The Intrinsic Value Of Cochlear Limited (ASX:COH)

Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal

Dec 24
Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal

Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly

Oct 30
Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly

This Is Why We Think Cochlear Limited's (ASX:COH) CEO Might Get A Pay Rise Approved By Shareholders

Oct 12
This Is Why We Think Cochlear Limited's (ASX:COH) CEO Might Get A Pay Rise Approved By Shareholders

A Look At The Fair Value Of Cochlear Limited (ASX:COH)

Oct 06
A Look At The Fair Value Of Cochlear Limited (ASX:COH)

Returns On Capital Signal Tricky Times Ahead For Cochlear (ASX:COH)

Aug 16
Returns On Capital Signal Tricky Times Ahead For Cochlear (ASX:COH)

Cochlear (ASX:COH) Has A Pretty Healthy Balance Sheet

Jun 24
Cochlear (ASX:COH) Has A Pretty Healthy Balance Sheet

A Look At The Intrinsic Value Of Cochlear Limited (ASX:COH)

May 17
A Look At The Intrinsic Value Of Cochlear Limited (ASX:COH)

Opbrengsten en kosten

Hoe Cochlear geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

ASX:COH Opbrengsten, kosten en inkomsten (AUD Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 242,236357898277
31 Mar 242,193354886273
31 Dec 232,149350874270
30 Sep 232,043326842257
30 Jun 231,936301810245
31 Mar 231,824281768230
31 Dec 221,713261725215
30 Sep 221,681275691213
30 Jun 221,648289658211
31 Mar 221,612273628208
31 Dec 211,575257597205
30 Sep 211,536291579200
30 Jun 211,498324560195
31 Mar 211,40382549187
31 Dec 201,308-160537180
30 Sep 201,314-199550182
30 Jun 201,321-238564185
31 Mar 201,40034569188
31 Dec 191,479306574190
30 Sep 191,453291560187
30 Jun 191,427277546184
31 Mar 191,422270535180
31 Dec 181,418264525175
30 Sep 181,391255510172
30 Jun 181,364246494168
31 Mar 181,329234475164
31 Dec 171,294223456160
30 Sep 171,274223444156
30 Jun 171,254224432152
31 Mar 171,218215426149
31 Dec 161,182206420146
30 Sep 161,156198412146
30 Jun 161,131189403145
31 Mar 161,088179383142
31 Dec 151,045168362138
30 Sep 15986157341133
30 Jun 15926146320128
31 Mar 15899145308126
31 Dec 14872144296124
30 Sep 14839119288126
30 Jun 1480594279128
31 Mar 1476985267129
31 Dec 1373276256130

Kwaliteitswinsten: COH heeft hoge kwaliteitsinkomsten.

Groeiende winstmarge: De huidige netto winstmarges (16%) COH } zijn hoger dan vorig jaar (15.5%).


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: De winst van COH is de afgelopen 5 jaar aanzienlijk gegroeid met 22.8% per jaar.

Versnelling van de groei: De winstgroei van COH over het afgelopen jaar ( 18.7% ) ligt onder het 5-jarig gemiddelde ( 22.8% per jaar).

Winst versus industrie: De winstgroei COH over het afgelopen jaar ( 18.7% ) overtrof de Medical Equipment -sector 18.7%.


Rendement op eigen vermogen

Hoge ROE: Het Rendement op eigen vermogen ( 19.4% ) van COH wordt als laag beschouwd.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden